menu
    • menu

    Company profile for Pluri

    NEW Drugs in Dev: 6
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We transform cells into solutions that promote global wellbeing and sustainability. From one core technology, we are developing next generation cell-based products across a range of fields and industries from pharma to food tech and beyond. Our technology was developed for nearly two decades to treat human disease. Now this technology is being harnessed far beyond medicine. We are developing platforms to expand high-quality ...
    We transform cells into solutions that promote global wellbeing and sustainability. From one core technology, we are developing next generation cell-based products across a range of fields and industries from pharma to food tech and beyond. Our technology was developed for nearly two decades to treat human disease. Now this technology is being harnessed far beyond medicine. We are developing platforms to expand high-quality human, plant and animal cells at large scale and low costs. This has a potential impact on every aspect of the life sciences. Our technology has the potential to be implemented in various industries.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PluriIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    MATAM Advanced Technology Park Building #5 Haifa 3508409, Israel
    Telephone
    Telephone
    +972-74-710-8600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.pluristem.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/pluristem-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Chairman Alejandro Weinstein Invests In Pluri With 30% Premium
    Chairman Alejandro Weinstein Invests In Pluri With 30% Premium

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3263000/11974/en/Pluri-Secures-Additional-Investment-from-Chairman-Alejandro-Weinstein-at-30-Premium-to-Market-in-a-Private-Placement.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Pluri Bolsters Global IP With China Patent For Immune Cell
    Pluri Bolsters Global IP With China Patent For Immune Cell

    18 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/18/3240180/11974/en/Pluri-Secures-Global-IP-Position-with-China-Patent-Grant-for-Large-Scale-Immune-Cell-Expansion-Complementing-Prior-U-S-Patent.html

    GLOBENEWSWIRE
    18 Feb 2026
    Share Share
    Pluri Completes First Phase of Resbiomed Biomaterials Program
    Pluri Completes First Phase of Resbiomed Biomaterials Program

    22 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/22/3223871/11974/en/Pluri-Successfully-Completes-First-Phase-of-Resbiomed-Program-for-Placenta-Derived-Collagen-Rich-Biomaterials.html

    GLOBENEWSWIRE
    22 Jan 2026
    Share Share
    Pluri, Remedy Cell Expand Collaboration for Successful Cells
    Pluri, Remedy Cell Expand Collaboration for Successful Cells

    22 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/22/3209102/11974/en/Pluri-and-Remedy-Cell-Expand-Collaboration-Successful-Engineering-Runs-and-Clinical-Grade-Manufacturing-Achieved.html

    GLOBENEWSWIRE
    22 Dec 2025
    Share Share
    Pluri Names Weinstein Chairman to Lead Strategic Shift
    Pluri Names Weinstein Chairman to Lead Strategic Shift

    09 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202360/11974/en/Pluri-Appoints-Alejandro-Weinstein-as-Chairman-of-the-Board-to-Lead-Strategic-Shift-and-Unlock-Value-Backed-by-Additional-Investment.html

    GLOBENEWSWIRE
    09 Dec 2025
    Share Share
    Pluri And Subsidiaries Named Bioagriculture Company Of The Year
    Pluri And Subsidiaries Named Bioagriculture Company Of The Year

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187268/11974/en/Pluri-and-Subsidiaries-Earn-Multiple-Industry-Honors-Named-as-Overall-BioAgriculture-Company-of-the-Year.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search